DOI QR코드

DOI QR Code

Prognostic Value of Lymph Node Ratios in Node Positive Rectal Cancer Treated with Preoperative Chemoradiation

  • Nadoshan, Jamal Jafari (Department of Surgical Oncology, Cancer Institute, Tehran University of Medical Science) ;
  • Omranipour, Ramesh (Department of Surgical Oncology, Cancer Institute, Tehran University of Medical Science) ;
  • Beiki, Omid (Kermanshah University of Medical Sciences) ;
  • Zendedel, Kazem (Cancer Research Center, Cancer Institute, Tehran University of Medical Science) ;
  • Alibakhshi, Abbas (Department of Surgical Oncology, Cancer Institute, Tehran University of Medical Science) ;
  • Mahmoodzadeh, Habibollah (Department of Surgical Oncology, Cancer Institute, Tehran University of Medical Science)
  • Published : 2013.06.30

Abstract

Background: To investigate the impact of the lymph node ratio (LNR) on the prognosis of patients with locally advanced rectal cancer undergoing pre-operative chemoradiation. Methods: Clinicopathologic and follow up data of 128 patients with stage III rectal cancer who underwent curative resection from 1996 to 2007 were reviewed. The patients were divided into two groups according to the lymph node ratio: LNR ${\leq}$ 0.2 (n=28), and >0.2 (n=100). Kaplan-Meier and the Cox proportional hazard regression models were used to evaluate the prognostic effects according to LNR. Results: Median numbers of lymph nodes examined and lymph nodes involved by tumour were 10.3 (range 2-28) and 5.8 (range 1-25), respectively, and the median LNR was 0.5 (range, 0-1.6). The 5-year survival rate significantly differed by LNR (${\leq}$ 0.2, 69%; >0.2, 19%; Log-rank p value < 0.001). LNR was also a significant prognostic factor of survival adjusted for age, sex, post-operative chemotherapy, total number of examined lymph nodes, metastasis and local recurrence (${\leq}$ 0.2, HR=1; >0.2, HR=4.8, 95%CI=2.1-11.1) and a significant predictor of local recurrence and distant metastasis during follow-up independently of total number of examined lymph node. Conclusions: Total number of examined lymph nodes and LNR were significant prognostic factors for survival in patients with stage III rectal cancer undergoing pre-operative chemoradiotherapy.

Keywords

Node ratio;rectal cancer;prognosis;preoperative chemoradiation

Acknowledgement

Supported by : Tehran University of Medical Sciences and Health Services

References

  1. Ainsworth PD, Johnson MA (2010). The prognostic significance of the metastatic lymph node ratio in Dukes stage C colorectal cancer in a district general hospital. Colorectal Dis, 12, 1219-22. https://doi.org/10.1111/j.1463-1318.2009.02026.x
  2. Baxter NN, Morris AM, Rothenberger DA, Tepper JE (2005). Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis. Int J Radiat Oncol Biol Phys, 61, 426-31. https://doi.org/10.1016/j.ijrobp.2004.06.259
  3. Ceelen W, Van Nieuwenhove Y, Pattyn P (2010). Prognostic value of the lymph node ratio in stage III colorectal cancer: a systematic review. Ann Surg Oncol, 17, 2847-55. https://doi.org/10.1245/s10434-010-1158-1
  4. Chin CC, Wang JY, Yeh CY, et al (2009). Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases in stage III colon cancer. Int J Colorectal Dis, 24, 1297-302. https://doi.org/10.1007/s00384-009-0738-7
  5. Dekker JWT, Peeters KC, Putter H, Vahrmeijer AL, van de Velde CJH (2010). Metastatic lymph node ratio in stage III rectal cancer; prognostic significance in addition to the 7th edition of the TNM classification. Eur J Surg Oncolm, 36, 1180-6. https://doi.org/10.1016/j.ejso.2010.09.007
  6. Edge SB, Compton CC (2010). The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 17, 1471-4. https://doi.org/10.1245/s10434-010-0985-4
  7. Edler D, Ohrling K, Hallstrom M, Karlberg M, Ragnhammar P (2007). The number of analyzed lymph nodes - a prognostic factor in colorectal cancer. Acta Oncol, 46, 975-81. https://doi.org/10.1080/02841860701203537
  8. Huh JW, Kim YJ, Kim HR (2010). Ratio of metastatic to resected lymph nodes as a prognostic factor in node-positive colorectal cancer. Ann Surg Oncol, 17, 2640-6. https://doi.org/10.1245/s10434-010-1015-2
  9. Kang J, Hur H, Min BS, Lee KY, Kim NK (2011). Prognostic impact of the lymph node ratio in rectal cancer patients who underwent preoperative chemoradiation. J Surg Oncol, 104, 53-8. https://doi.org/10.1002/jso.21913
  10. Kotake K, Honjo S, Sugihara K, et al (2012). Number of lymph nodes retrieved is an important determinant of survival of patients with stage II and stage III colorectal cancer. Jpn J Clin Oncol, 42, 29-35. https://doi.org/10.1093/jjco/hyr164
  11. Kim YS, Kim JH, Yoon SM, et al (2009). Lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. Int J Radiat Oncol Biol Phys, 74, 796-802. https://doi.org/10.1016/j.ijrobp.2008.08.065
  12. Lee SD, Kim TH, Kim DY, et al (2012). Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection. Eur J Surg Oncol, 38, 478-83. https://doi.org/10.1016/j.ejso.2012.03.002
  13. Manilich EA, Kiran RP, Radivoyevitch T, et al (2011). A novel data-driven prognostic model for staging of colorectal cancer. J Am College Surg, 213, 579-88. https://doi.org/10.1016/j.jamcollsurg.2011.08.006
  14. Marks JH, Valsdottir EB, Rather AA, et al (2010). Fewer than 12 lymph nodes can be expected in a surgical specimen after high-dose chemoradiation therapy for rectal cancer. Dis Colon Rectum, 53, 1023-9. https://doi.org/10.1007/DCR.0b013e3181dadeb4
  15. Mekenkamp LJ, van Krieken JH, Marijnen CA, van de Velde CJ, Nagtegaal ID (2009). Lymph node retrieval in rectal cancer is dependent on many factors--the role of the tumor, the patient, the surgeon, the radiotherapist, and the pathologist. Am J Surg Pathol, 33, 1547-53. https://doi.org/10.1097/PAS.0b013e3181b2e01f
  16. Nagtegaal ID, van de Velde CJ, van der Worp E, et al (2002). Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol, 20, 1729-34. https://doi.org/10.1200/JCO.2002.07.010
  17. Park YH, Lee JI, Park JK, et al (2011). Clinical significance of lymph node ratio in stage III colorectal cancer. J Korean Soc Coloproctol, 27, 260-5. https://doi.org/10.3393/jksc.2011.27.5.260
  18. Peng J, Xu Y, Guan Z, et al (2008). Prognostic significance of the metastatic lymph node ratio in node-positive rectal cancer. Ann Surg Oncol, 15, 3118-23. https://doi.org/10.1245/s10434-008-0123-8
  19. Peschaud F, Benoist S, Julie C, et al (2008). The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer. Ann Surg, 248, 1067-73. https://doi.org/10.1097/SLA.0b013e31818842ec
  20. Priolli DG, Cardinalli IA, Pereira JA, et al (2009). Metastatic lymph node ratio as an independent prognostic variable in colorectal cancer: study of 113 patients. Tech Coloproctol, 13, 113-21 https://doi.org/10.1007/s10151-009-0467-5
  21. Qiu HB, Zhang LY, Li YF, et al (2011). Ratio of metastatic to resected lymph nodes enhances to predict survival in patients with stage III colorectal cancer. Ann Surg Oncol, 18, 1568-74. https://doi.org/10.1245/s10434-010-1528-8
  22. Rosenberg R, Friederichs J, Schuster T, et al (2008). Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period. Ann Surg, 248, 968-78. https://doi.org/10.1097/SLA.0b013e318190eddc
  23. Rosenberg R, Engel J, Bruns C, et al (2010). The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients. Ann Surg, 251, 1070-8. https://doi.org/10.1097/SLA.0b013e3181d7789d
  24. Rullier A, Laurent C, Capdepont M, et al (2008). Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival. Am J Surg Pathol, 32, 45-50. https://doi.org/10.1097/PAS.0b013e3180dc92ab
  25. Sermier A, Gervaz P, Egger JF, et al (2006). Lymph node retrieval in abdominoperineal surgical specimen is radiation timedependent. World J Surg Oncol, 4, 29. https://doi.org/10.1186/1477-7819-4-29
  26. Shimomura M, Ikeda S, Takakura Y, et al (2011). Adequate lymph node examination is essential to ensure the prognostic value of the lymph node ratio in patients with stage III colorectal cancer. Surg Today, 41, 1370-9. https://doi.org/10.1007/s00595-010-4446-2
  27. Simunovic M, Smith AJ, Heald RJ (2009). Rectal cancer surgery and regional lymph nodes. J Surg Oncol, 99, 256-9. https://doi.org/10.1002/jso.21217
  28. Thomas M, Biswas S, Mohamed F, et al (2012). Dukes C colorectal cancer: is the metastatic lymph node ratio important? Int J Colorectal Dis, 27, 309-17. https://doi.org/10.1007/s00384-011-1340-3
  29. Tong LL, Gao P, Wang ZN, et al (2011). Can lymph node ratio take the place of pN categories in the UICC/AJCC TNM classification system for colorectal cancer? Ann Surg Oncol, 18, 2453-60 https://doi.org/10.1245/s10434-011-1687-2
  30. Wichmann MW, Muller C, Meyer G, et al (2002). Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer. Arch Surgery, 137, 206-10. https://doi.org/10.1001/archsurg.137.2.206
  31. Wong KP, Poon JT, Fan JK, Law WL (2011). Prognostic value of lymph node ratio in stage III colorectal cancer. Colorectal Dis, 13, 1116-22. https://doi.org/10.1111/j.1463-1318.2010.02435.x

Cited by

  1. Prognostic Value of Total Lymph Node Identified and Ratio of Lymph Nodes in Resected Colorectal Cancer vol.1, pp.3, 2013, https://doi.org/10.17795/acr-15311
  2. Lymph Node Ratio is an Independent Prognostic Factor in Node Positive Rectal Cancer Patients Treated with Preoperative Chemoradiotherapy Followed by Curative Resection vol.15, pp.13, 2014, https://doi.org/10.7314/APJCP.2014.15.13.5365
  3. An Overview of Clinical and Pathological Characteristics and Survival Rate of Colorectal Cancer in Iran vol.2, pp.1, 2014, https://doi.org/10.17795/acr-17264
  4. Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy vol.10, pp.9, 2015, https://doi.org/10.1371/journal.pone.0138728
  5. A Logistic Model Including Risk Factors for Lymph Node Metastasis Can Improve the Accuracy of Magnetic Resonance Imaging Diagnosis of Rectal Cancer vol.16, pp.2, 2015, https://doi.org/10.7314/APJCP.2015.16.2.707
  6. Prognostic Factors and the Role of Adjuvant Chemotherapy in Post-curative Surgery for Dukes B and C Colon Cancers and Survival Outcomes: a Malaysian Experience vol.16, pp.6, 2015, https://doi.org/10.7314/APJCP.2015.16.6.2237
  7. Is da Vinci Xi Better than da Vinci Si in Robotic Rectal Cancer Surgery? Comparison of the 2 Generations of da Vinci Systems vol.26, pp.5, 2016, https://doi.org/10.1097/SLE.0000000000000320
  8. Lymph node ratio is an independent prognostic factor for rectal cancer after neoadjuvant therapy: A meta-analysis vol.11, pp.3, 2018, https://doi.org/10.1111/jebm.12289